If you have any question, please feel free to email us. We will touch with you as soon as possible.
CAS:104121-92-8
Source:Korea
Qualifications:-/-/-/-/-
| Name | Idecalcidol |
|---|---|
| Chinese name | 艾地骨化醇 |
| Cas Number | 104121-92-8 |
| Source | Korea |
| Qualifications | -/-/-/-/- |
Japan’s Ministry of Health, Welfare and Welfare approved the market for osteoporosis treatment drug-idecalcidol soft capsules on January 21, 2011. Its effective substance idecalcidol is another new treatment for bone after alfacalcidol. An active vitamin D3 derivative for cytoporosis. Idecalcidol is an analog of vitamin D, which can increase bone density more effectively and reduce the risk of fractures. It is the latest treatment for osteoporosis. A 3-year phase III clinical data involving 1054 patients with osteoporosis showed that alfacalcidol is more effective than alfacalcidol, and its safety is similar to that of alfacalcidol. Application prospects.
Hot Tags: idecalcidol api, China, suppliers, manufacturers, factory, customized, price, pricelist, in stock, Deoxycholic Acid API, Lercanidipine Hydrochloride API, Linagliptin API, Lurasidone Hydrochloride API, Tetrabenazine API, Fulvestrant API
Tel:+86-020-61855200-902
Fax:+86-020-66392525
Email:info@upharm.cn
Address:12th floor, No. 181, Kexue Avenue, Huangpu District, Guangzhou, China
